KOE:145020
Hugel, Inc. · KOE · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 13:24 UTC
Last close
n/aKRW
Market data
14.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
19.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
33.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
32.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth15.0%68 of 100, above its sector
- Returns on capital19.5%86 of 100, above its sector
- Margins76.0%94 of 100, above its sector
- Price14.4x49 of 100, above its sector
- Safety0.0392 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.45x
Its own average over 7 years, 292.43B.
- Profit1.73x
Its own average over 7 years, 81.63B.
- Free cash flow1.93x
Its own average over 7 years, 70.93B.
- Debt0.38x
Its own average over 7 years, 77.17B.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 1.93 times.
Sales is 1.45 times its own 7-year average; Profit is 1.73 times its own 7-year average; Free cash flow is 1.93 times its own 7-year average; Debt is 0.38 times its own 7-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 7-year average1.45
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Profit against its own 7-year average1.73
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Free cash flow against its own 7-year average1.93
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Debt against its own 7-year average0.38
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- KRW